Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22therapy.%22&type=Subject&filter%5B%5D=collection%3ACTG
/vufind/Search/Results?lookfor=%22therapy.%22&type=Subject&filter%5B%5D=collection%3ACTG
Search /vufind/Search2/Results?lookfor=%22therapy.%22&type=Subject&filter%5B%5D=collection%3ACTG
PubPharm (10.535)
1
A study to compare the efficacy and safety of bb2121 to standard treatment in people who have Myeloma that is not responsive after treatment or who had Myeloma which has returned after a period of treatment. : A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of BB2121 Versus Standard Triplet Regimens in Subjects with Relapsed and Refractory Multiple Myeloma (Rrmm) (KarMMa-3)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
High-dose intravenous silibinin infusions during 10 days as add-on treatment to triple therapy (telaprevir, peginterferon alpha and ribavirin) in cirrhotic GT 1 hepatitis C virus infected patients being null responders to prior dual therapy with peginterferon alpha and ribavirin – a proof-of-concept trial on antiviral efficacy and safety : High-dose intravenous silibinin infusions during 10 days as add-on treatment to triple therapy (telaprevir, peginterferon alpha and ribavirin) in cirrhotic GT 1 hepatitis C virus infected patients being null responders to prior dual therapy with peginterferon alpha and ribavirin – a proof-of-concept trial on antiviral efficacy and safety - HISTORY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Long term continuous infusion ch14.18/CHO plus s.c. aldesleukin (IL-2) randomised : A PHASE I/II DOSE SCHEDULE FINDING STUDYFOR CH14.18/CHO CONTINUOUS INFUSION COMBINED WITH SUBCUTANEOUS ALDESLEUKIN (IL-2)IN PATIENTS WITH PRIMARY REFRACTORY OR RELAPSING NEUROBLASTOMA - Long term continuous infusion ch14.18/CHO
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A global study to assess the efficacy and safety of durvalumab in combination with bevacizumab or durvalumab alone in patients with hepatocellular carcinoma who are at high risk of recurrence : A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi Center Study of Durvalumab Monotherapy or in Combination With Bevacizumab as Adjuvant Therapy in Patients With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation - EMERALD-2
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Study of efficacy and safety of pembrolizumab plus platinum-based doublet chemotherapy with or without canakinumab in previously untreated locally advanced or metastatic non-squamous and squamous NSCLC subjects : A randomized, double-blind, placebo-controlled, phase III study evaluating the efficacy and safety of pembrolizumab plus platinum-based doublet chemotherapy with or without canakinumab as first line therapy for locally advanced or metastatic non-squamous and squamous non-small cell lung cancer subjects (CANOPY-1)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Study of Letrozole Extension (SOLE) : A phase III trial evaluating the role of continuous letrozole versus intermittent letrozole following 4 to 6 years of prior adjuvant endocrine therapy for postmenopausal women with hormone-receptor positive, node positive early stage breast cancer - Study of Letrozole Extension (SOLE)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Study the effect of Landiolol on elevated heart rate by septic shock patients : Phase IV, multicenter, prospective, randomized, open-label, controlled study on Landiolol in patients with septic shock resident in an Intensive Care Unit - LANDI-SEP
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Randomized, double blind, safety, efficacy Doravirine/Islatravir in Treatment naïve : A Phase 3 Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Antiretroviral Activity, Safety, and Tolerability of Doravirine/Islatravir Once-Daily in HIV-1 Infected Treatment-Naïve Participants - Randomized, double blind, safety, efficacy Doravirine/Islatravir in Tx naïve
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy : A Double-blind, Placebo-controlled Study to Evaluate New or Worsening Lens Opacifications in Subjects with Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss due to Androgen-Deprivation Therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
BMC2012, Cell based therapy by implanted bone marrow-derived mononuclear cells (BMC) for bone augmentation of plate-stabilized proximal humeral fractures - a randomized, open, multicentric study - phase IIa : BMC2012, Cell based therapy by implanted bone marrow-derived mononuclear cells (BMC) for bone augmentation of plate-stabilized proximal humeral fractures - a randomized, open, multicentric study - phase IIa - Cell based therapy by implanted BMC for bone augmentation of humeral fractures, Phase IIa
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1054]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
10.535
Aufsätze
10.535
E-Artikel
10.535
E-Ressourcen
Zeitschriftentitel
9.030
WHO International Clinical Trials Registry Plat...
1.505
ClinicalTrials.gov
Thema
10.535
610
9.583
Study Type: Interventional
4.733
Recruitment Status: Not yet recruiting
2.132
Recruitment Status: Completed
1.690
Phase: Phase 3
1.484
Recruitment Status: Authorised-recruitment may ...
1.345
Phase: Phase 2
1.237
Recruitment Status: Recruiting
800
Study Type: Observational
571
Phase: Phase 4
451
Phase: Phase 1
254
Recruitment Status: Complete: follow-up complete
179
Recruitment Status: Unknown status
91
Phase: Phase 2/Phase 3
85
Phase: Phase 1/Phase 2
82
Recruitment Status: Terminated
72
Study Type: Observational non invasive
68
Recruitment Status: Complete: follow-up continuing
65
Recruitment Status: Active, not recruiting
54
Recruitment Status: Withdrawn
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
5.596
2020-
4.897
2010-2019
42
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
10.313
Englisch
80
Unbestimmt
56
Niederländisch
40
Spanisch
16
Deutsch
8
Dänisch
8
Französisch
4
Schwedisch
2
Corsican
2
Ungarisch
2
Italienisch
2
Norwegisch
2
Portugiesisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...